Can we identify genes for alcohol consumption in samples ascertained for heterogeneous purposes?
- Authors
- Hansell, Narelle K; Agrawal, Arpana; Whitfield, John B; Morley, Katherine I; Gordon, Scott D; Lind, Penelope A; Pergadia, Michele L; Montgomery, Grant W; Madden, Pamela A F; Todd, Richard D; Heath, Andrew C; Martin, Nicholas G
- Year
- 2009
- Journal
- Alcoholism, clinical and experimental research
- PMID
- 19183129
- DOI
- 10.1111/j.1530-0277.2008.00890.x
- PMCID
- PMC3164813
BACKGROUND: Previous studies have identified evidence of genetic influence on alcohol use in samples selected to be informative for alcoholism research. However, there are a growing number of genome-wide association studies (GWAS) using samples unselected for alcohol consumption (i.e., selected on other traits and forms of psychopathology), which nevertheless assess consumption as a risk factor. Is it reasonable to expect that genes contributing to variation in alcohol consumption can be identified in such samples? METHODS: An exploratory approach was taken to determine whether linkage analyses for heaviness of alcohol consumption, using a sample collected for heterogeneous purposes, could replicate previous findings. Quantity and frequency measures of consumption were collected in telephone interviews from community samples. These measures, and genotyping, were available for 5,441 individuals (5,067 quasi-independent sibling pairs). For 1,533 of these individuals, data were collected on 2 occasions, about 8.2 years apart, providing 2 datasets that maximize data collected at either a younger or an older age. Analyses were conducted to address the question of whether age and heavier levels of alcohol consumption effects outcome. Linkage results were compared in the younger and older full samples, and with samples in which approximately 10, 20, and 40 of drinkers from the lower end of the distribution of alcohol consumption were dropped. RESULTS: Linkage peaks varied for the age differentiated samples and for percentage of light drinkers retained. Larger peaks (LOD scores >2.0) were typically found in regions previously identified in linkage studies and/or containing proposed candidate genes for alcoholism including AGT, CARTPT, OPRD1, PIK3R1, and PDYN. CONCLUSIONS: The results suggest that GWAS assessing alcohol consumption as a covariate for other conditions will have some success in identifying genes contributing to consumption-related variation. However, sample characteristics, such as participant age, and trait distribution, may have substantial effects on the strength of the genetic signal. These results can inform forthcoming GWAS where the same restrictions apply.
Linkage plots for Quantity × Frequency, Quantity, and Frequency with full and truncated samples (100%, 90%, 80%, & 60%), for the older and younger datasets, are shown for the 22 autosomal chromosomes and the X chromosome.
LLM interpretation
This figure consists of 12 linkage plots organized into three main sections: "Quantity x Frequency," "Quantity," and "Frequency," each showing results for four sample sizes (100%, 90%, 80%, and 60%). The x-axes represent the 22 autosomal chromosomes and the X chromosome, while the y-axes show LOD scores. Each plot compares "Older" (red line) and "Younger" (blue line) datasets, displaying varying peaks of genetic linkage across the chromosomes.
Linkage on chromosome 6 for Quantity × Frequency with full and truncated samples (100%, 90%, 80%, 60%), using the younger dataset, and with the location of the candidate gene NRN1 (neuritin 1) indicated.
LLM interpretation
This line graph shows the LOD score across the map distance (Cm) of chromosome 6 for the "Quantity x Frequency" trait in a younger dataset. Four sample sizes are compared (100%, 90%, 80%, and 60%), with the 100% and 90% samples showing a prominent peak in LOD score (reaching approximately 3.25) between 10 and 30 Cm. The candidate gene *NRN1* is indicated by an arrow at approximately 12 Cm, coinciding with the primary peak of the full and 90% sample datasets.
Linkage on chromosome 1 for Quantity × Frequency with full and truncated samples (100%, 90%, 80%, 60%), using the younger dataset, and showing the location of candidate genes STX12 (syntaxin 12-binding protein), OPRD1 (opioid receptor, delta-1), DHX9 (DEAH (Asp-Glu-Ala_His) box Polypeptide 9), and AGT (angiotensinogen).
LLM interpretation
This line graph shows the LOD score across the map distance (Cm) of chromosome 1 for the "Quantity x Frequency" trait in a younger dataset. Four lines represent different sample sizes (100%, 90%, 80%, and 60%), with the 80% sample showing the highest peak LOD score (approximately 2.75) near the AGT gene. Two primary peaks are visible: one between 30–50 Cm near the STX12 and OPRD1 genes, and another between 180–240 Cm near the DHX9 and AGT genes.
Linkage on chromosome 3 for quantity and frequency measures with full and/or truncated samples (100%, 60%), using the older dataset, and showing the location of the candidate genes TRH (thyrotropin-releasing hormone) and SOX2 (SRY (sex determining region Y) – box 2).
LLM interpretation
This line graph shows LOD scores across the map distance (cM) of chromosome 3 for four different dataset conditions: Quantity 100%, Quantity 60%, Frequency 100%, and Quantity x Frequency 60%. The "Quantity 100%" group exhibits the highest peak (LOD score ~2.7) near the TRH gene location, while the "Quantity x Frequency 60%" group shows a prominent peak (LOD score ~2.5) near the SOX2 gene location. The x-axis represents map distance in centimorgans (cM), and the y-axis represents the LOD score.
Linkage on chromosome 5 for Frequency with full and truncated samples (100%, 90%, 80%, 60%), using the older dataset and showing the genes CARTPT (cocaine- and amphetamine-regulated transcript (CART) prepropeptide) and PIK3R1 ((phosphoinositide-e-kinase, regulatory subunit 1 (alpha)).
LLM interpretation
This line graph shows the LOD score across the map distance (Cm) of chromosome 5 for four different sample sizes (100%, 90%, 80%, and 60%) using an older dataset. The x-axis represents map distance in centimorgans, and the y-axis represents the LOD score. A prominent peak is observed around 80-90 Cm, which increases in magnitude as the sample percentage decreases, with the 60% sample reaching the highest LOD score of approximately 2.5 near the labeled genes *CARTPT* and *PIK3R1*.
| Name | Type |
|---|---|
| Actual number of drinks recorded local | phenotype |
| ADH1B | gene |
| age | phenotype |
| Age2 local | phenotype |
| AGT | gene |
| alcohol | phenotype |
| alcohol dependence | phenotype |
| alcoholism | phenotype |
| alcohol-related phenotypes | phenotype |
| Alcohol Use | phenotype |
| amelogenin local | gene |
| ATA109H09 local | variant |
| ATA28B11 local | variant |
| ATA85B10 local | variant |
| Australian Genome Research Facility local | cohort |
| Australian Twin Registry (ATR) local | cohort |
| blood group local | phenotype |
| British ancestry local | phenotype |
| cancer | phenotype |
| CARTPT | gene |
| Categorical drinking response local | phenotype |
| Children of twins local | cohort |
| chromosome 1 local | variant |
| Chromosome 18 local | variant |
| Chromosome 20 local | variant |
| Chromosome 3 local | variant |
| chromosome 6 local | variant |
| Chromosome 6 local | variant |
| Chronic health conditions | phenotype |
| Cohort_1642_parents local | cohort |
| Cohort_5441_individuals local | cohort |
| Collaborative Study on the Genetics of Alcoholism (COGA) | cohort |
| combined cohort | cohort |
| Complete twin pairs local | cohort |
| consumption | phenotype |
| control | cohort |
| controls | cohort |
| D1S1612 local | variant |
| D1S199 local | variant |
| D1S225 local | variant |
| D1S2667 local | variant |
| D1S2697 local | variant |
| D1S491 local | variant |
| D2S1612 local | variant |
| D3S1267 local | variant |
| D3S1292 local | variant |
| D3S2460 local | variant |
| D6S344 local | variant |
| D6S470 local | variant |
| drinkers | phenotype |
| drinking | phenotype |
| drinks per week | phenotype |
| DXS6789 local | variant |
| DXS6800 local | variant |
| DXS8029 local | variant |
| DZ pair local | cohort |
| European ancestry | cohort |
| Family History of Substance Abuse Samples local | cohort |
| Finnish Genome Centre local | cohort |
| first two phases of telephone interviews local | cohort |
| frequency | phenotype |
| full sample | cohort |
| GABRA2 | gene |
| GATA141B10 local | variant |
| GATA152F04 local | variant |
| GATA88F03 local | variant |
| GATA92B06 local | variant |
| Gemini Genomics local | cohort |
| general population | cohort |
| genome scans local | cohort |
| GRR local | drug |
| heavy drinking | phenotype |
| hypertension | phenotype |
| intermediate samples local | cohort |
| Irish ancestry local | phenotype |
| Lange-Goradia genotype elimination algorithm local | drug |
| light drinkers | phenotype |
| Low bone density local | phenotype |
| Low consumption local | phenotype |
| low consumption levels local | phenotype |
| Marshfield Clinic's Mammalian Genotyping Service local | cohort |
| Merlin | drug |
| most concentrated sample local | cohort |
| Non-twin siblings local | cohort |
| older cohort | cohort |
| older cohort (28–90 years) local | cohort |
| older dataset local | cohort |
| Older dataset local | cohort |
| Oprd1 | cohort |
| outlier | phenotype |
| Parental pairs local | cohort |
| parents | cohort |
| Pdyn | gene |
| pedtool local | drug |
| phase three telephone interview participants local | cohort |
| PIK3R1 | gene |
| QISP local | phenotype |
| quantity | phenotype |
| Quantity × Frequency local | phenotype |
| Quantity × Frequency score local | phenotype |
| Quasi-independent sibling pairs (QISPs) local | cohort |
| Queensland Institute of Medical Research | cohort |
| Relpair | drug |
| samples | cohort |
| SE30 local | variant |
| Sequana Therapeutics local | cohort |
| sex | phenotype |
| sibling pair local | phenotype |
| smoking | phenotype |
| study cohort | cohort |
| sub-sample local | cohort |
| Truncated sample 60% local | cohort |
| Truncated sample 80% local | cohort |
| Truncated sample 90% local | cohort |
| Twin cohort | cohort |
| University of Leiden local | cohort |
| Unselected Samples local | cohort |
| voluntary alcohol consumption | phenotype |
| X chromosome | drug |
| younger cohort | cohort |
| younger cohort (23–39 years) local | cohort |
| younger dataset local | cohort |
| Younger dataset local | cohort |
| younger twin cohort local | cohort |
| zygosity | phenotype |
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Delta Opioid Pharmacology in Relation to Alcohol Behaviors. | Alongkronrusmee D et al. | — | 2018 | → |
| Effects of high alcohol intake, alcohol-related symptoms and smoking on mortality. | Whitfield JB et al. | — | 2018 | → |
| Polygenic Risk Score Prediction of Alcohol Dependence Symptoms Across Population-Based and Clinically Ascertained Samples. | Savage JE et al. | — | 2018 | → |
| Association of OPRD1 polymorphisms with heroin dependence in a large case-control series. | Nelson EC et al. | — | 2014 | → |
| Alcohol consumption in men is influenced by qualitatively different genetic factors in adolescence and adulthood. | Edwards AC et al. | — | 2013 | → |
| ANKK1, TTC12, and NCAM1 polymorphisms and heroin dependence: importance of considering drug exposure. | Nelson EC et al. | — | 2013 | → |
| The dynorphin/κ-opioid receptor system and its role in psychiatric disorders. | Tejeda HA et al. | — | 2012 | → |
| Linkage analysis of alcohol dependence symptoms in the community. | Hansell NK et al. | — | 2010 | → |
| Alcohol consumption indices of genetic risk for alcohol dependence. | Grant JD et al. | — | 2009 | → |
| Genetical genomic determinants of alcohol consumption in rats and humans. | Tabakoff B et al. | — | 2009 | → |